| 000 | 02755 a2200697 4500 | ||
|---|---|---|---|
| 005 | 20250514203804.0 | ||
| 264 | 0 | _c20050331 | |
| 008 | 200503s 0 0 eng d | ||
| 022 | _a1466-4860 | ||
| 024 | 7 |
_a10.1038/sj.thj.6200536 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aThomas, Xavier | |
| 245 | 0 | 0 |
_aEfficacy of granulocyte and granulocyte-macrophage colony-stimulating factors in the induction treatment of adult acute lymphoblastic leukemia: a multicenter randomized study. _h[electronic resource] |
| 260 |
_bThe hematology journal : the official journal of the European Haematology Association _c2004 |
||
| 300 |
_a384-94 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 |
_aDaunorubicin _xadministration & dosage |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 |
_aDrug Utilization _xstatistics & numerical data |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFever _xetiology |
| 650 | 0 | 4 |
_aGranulocyte Colony-Stimulating Factor _xpharmacology |
| 650 | 0 | 4 |
_aGranulocyte-Macrophage Colony-Stimulating Factor _xpharmacology |
| 650 | 0 | 4 |
_aHospitalization _xstatistics & numerical data |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIdarubicin _xadministration & dosage |
| 650 | 0 | 4 | _aInfection Control |
| 650 | 0 | 4 |
_aInfections _xepidemiology |
| 650 | 0 | 4 | _aLeukocyte Count |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeutropenia _xchemically induced |
| 650 | 0 | 4 |
_aNeutrophils _xdrug effects |
| 650 | 0 | 4 |
_aPrecursor Cell Lymphoblastic Leukemia-Lymphoma _xblood |
| 650 | 0 | 4 |
_aPrednisone _xadministration & dosage |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aSalvage Therapy |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVincristine _xadministration & dosage |
| 700 | 1 | _aBoiron, Jean-Michel | |
| 700 | 1 | _aHuguet, Françoise | |
| 700 | 1 | _aReman, Oumedaly | |
| 700 | 1 | _aSutton, Laurent | |
| 700 | 1 | _aTurlure, Pascal | |
| 700 | 1 | _aGarban, Frédéric | |
| 700 | 1 | _aGardin, Claude | |
| 700 | 1 | _aEspinouse, Daniel | |
| 700 | 1 | _aBoulat, Olivier | |
| 700 | 1 | _aLhéritier, Véronique | |
| 700 | 1 | _aFiere, Denis | |
| 773 | 0 |
_tThe hematology journal : the official journal of the European Haematology Association _gvol. 5 _gno. 5 _gp. 384-94 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.thj.6200536 _zAvailable from publisher's website |
| 999 |
_c15141249 _d15141249 |
||